Literature DB >> 28688029

Patterns of a Rectal Microbicide Placebo Gel Use in a Preparatory Stage for a Phase I Trial Among Young Men Who Have Sex with Men.

José A Bauermeister1, R Giguere2, C S Leu2,3, C Dolezal2, I Febo4, R D Cranston5, K Mayer6, I McGowan7, A Carballo-Diéguez2.   

Abstract

We examined young gay, bisexual, and other men who have sex with men's (YGBMSM) usage patterns of a pre-coital, applicator-administered rectal placebo gel. An ethnically diverse sample of 94 YGBMSM (aged 18-30 years) were asked to insert hydroxyethylcellulose placebo gel rectally before receptive anal intercourse (RAI) and report their gel use through an interactive voice response system (IVRS) across 12 weeks. We used trajectory analyses to characterize participants' use of the rectal gel over the 12 weeks, and examine whether these trajectories varied based on participants' sociodemographic characteristics, sexual behaviors, application and insertion behaviors, and experiences using the placebo gel. A cubic model was the best fit for these longitudinal data, with two distinct trajectories of gel use observed. The first trajectory ('High with Varying Gel Use per Week') represented YGBMSM (N = 38; 40.3%) who reported using the rectal gel on several occasions per week. The second trajectory ('Low and Consistent Gel Use per Week') represented participants (N = 56; 59.7%) who reported a consistent average use of one gel per week. Participants in the High with Varying Gel Use Trajectory reported trying out a greater number of positions when inserting the gel across the 12-weeks than peers in the Low and Consistent Gel Use Trajectory. YGBMSM reporting more RAI occasions during the trial were more likely be present in the High with Varying Gel Use Trajectory than peers in the Low and Consistent Gel Use Trajectory. Future research examining how to facilitate gel application and adherence among YGBMSM is merited.

Entities:  

Keywords:  Acceptability; Applicator satisfaction; Gay; HIV/AIDS; Prevention; Rectal microbicide

Mesh:

Substances:

Year:  2018        PMID: 28688029      PMCID: PMC5756684          DOI: 10.1007/s10461-017-1847-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  23 in total

1.  High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.

Authors:  A van der Straten; E T Montgomery; H Cheng; L Wegner; G Masenga; C von Mollendorf; L Bekker; S Ganesh; K Young; J Romano; A Nel; C Woodsong
Journal:  AIDS Behav       Date:  2012-10

2.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

3.  Sexual Partner Typologies and the Association Between Drug Use and Sexual Risk Behavior Among Young Men Who Have Sex With Men.

Authors:  Patrick Janulis; Brian A Feinstein; Gregory Phillips; Michael E Newcomb; Michelle Birkett; Brian Mustanski
Journal:  Arch Sex Behav       Date:  2017-02-13

4.  Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).

Authors:  Pamina M Gorbach; Clifton W Kelly; Joleen A Borgerding; Gita Ramjee; Tchangani Tembo; Newton Kumwenda; Petina Musara; Sarah Roberts; Lisa Maslankowski
Journal:  AIDS Behav       Date:  2014-05

5.  Adherence to rectal gel use among mainly ethnic minority young men who have sex with men during a 3-month placebo gel trial: implications for microbicide research.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; José Bauermeister; Cheng-Shiun Leu; Juan Valladares; Timothy Frasca; Rita Labbett; Ross D Cranston; Irma Febo; Kenneth Mayer; Ian McGowan
Journal:  AIDS Behav       Date:  2014-09

6.  Rectal microbicide acceptability: results of a volume escalation trial.

Authors:  Alex Carballo-Diéguez; Theresa Exner; Curtis Dolezal; Robert Pickard; Peter Lin; Kenneth H Mayer
Journal:  Sex Transm Dis       Date:  2007-04       Impact factor: 2.830

7.  Rectal microbicides: can we make them and will people use them?

Authors:  Ian McGowan
Journal:  AIDS Behav       Date:  2011-04

Review 8.  The development of rectal microbicides for HIV prevention.

Authors:  Ian McGowan
Journal:  Expert Opin Drug Deliv       Date:  2013-11-25       Impact factor: 6.648

9.  Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial.

Authors:  Heather A Pines; Pamina M Gorbach; Robert E Weiss; Kristen Hess; Ryan Murphy; Terry Saunders; Joelle Brown; Peter A Anton; Ross D Cranston
Journal:  AIDS Behav       Date:  2013-03

10.  Interactive Voice Response System: Data Considerations and Lessons Learned During a Rectal Microbicide Placebo Adherence Trial for Young Men Who Have Sex With Men.

Authors:  Jose Bauermeister; Rebecca Giguere; Cheng-Shiun Leu; Irma Febo; Ross Cranston; Kenneth Mayer; Alex Carballo-Diéguez
Journal:  J Med Internet Res       Date:  2017-06-09       Impact factor: 5.428

View more
  4 in total

1.  Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche.

Authors:  Alex Carballo-Dieguez; Rebecca Giguere; Cody Lentz; Curtis Dolezal; Edward J Fuchs; Craig W Hendrix
Journal:  AIDS Behav       Date:  2019-06

2.  Trajectory of use over time of an oral tablet and a rectal gel for HIV prevention among transgender women and men who have sex with men.

Authors:  Cheng-Shiun Leu; Rebecca Giguere; José A Bauermeister; Curtis Dolezal; William Brown; Ivan C Balán; Barbra A Richardson; Jeanna M Piper; Javier R Lama; Ross D Cranston; Alex Carballo-Diéguez
Journal:  AIDS Care       Date:  2018-10-14

3.  Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026).

Authors:  José A Bauermeister; Ryan C Tingler; Clara Dominguez; Eileen F Dunne; Craig Hoesley; Ken Ho; Sherri Johnson; Jonathan Lucas; Nicole Macagna; Elizabeth Brown; Holly Gundacker; Melissa Peda; Cindy E Jacobson; Lindsay Kramzer; Devika Singh; Charlene S Dezzutti; Ratiya Pamela Kunjara Na Ayudhya; Mark A Marzinke; Jeanna Piper; Bríd Devlin; Jeremy Nuttall; Ian McGowan; Craig W Hendrix; Ross D Cranston
Journal:  AIDS Behav       Date:  2021-10-17

4.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.